Estudo de Cambridge revela potencial para reverter danos nervosos

Pesquisadores da Universidade de Cambridge desenvolveram modelos miniatura de cérebro e medula espinhal humanos cultivados em laboratório, que mostram que fibras nervosas danificadas podem recuperar a capacidade de regeneração sob certas condições.

A equipe construiu circuitos neurais funcionais usando organoides derivados de células-tronco mantidos fisicamente separados em laboratório. Axônios do tecido cerebral cresceram através do espaço para se conectar ao tecido da medula espinhal e desencadear contrações musculares. Essa configuração permitiu o estudo da regeneração ao longo de mais de um ano de desenvolvimento.

Artigos relacionados

Illustration of mitochondria transferring from glia to neurons to reduce nerve pain in neuropathy models.
Imagem gerada por IA

Duke-led Nature study links glia-to-neuron mitochondria transfer to reduced nerve pain in neuropathy models

Reportado por IA Imagem gerada por IA Verificado

Duke University researchers report that boosting the transfer of healthy mitochondria from support cells to sensory neurons reduced pain-like behaviors in mouse models of diabetic and chemotherapy-related peripheral neuropathy, an approach they say could address a root driver of nerve pain rather than simply blocking pain signals.

Researchers in Japan have created new vitamin K compounds that are three times more effective than natural forms at turning stem cells into neurons. The work, published in 2025, targets diseases that destroy brain cells such as Alzheimer’s and Parkinson’s.

Reportado por IA

Researchers have shown that rejuvenating muscle stem cells from old mice leads to larger muscle growth and improved recovery after injury. The approach could one day help older people regain strength and mobility. Experiments demonstrated clear benefits in leg function and tissue repair.

A widely studied anti-aging treatment triggered significant brain damage in mice, according to new research from the University of Connecticut. The drug combination dasatinib plus quercetin caused myelin loss and changes resembling those seen in multiple sclerosis. The findings raise questions about its use in longevity studies and off-label therapies.

Este site usa cookies

Usamos cookies para análise para melhorar nosso site. Leia nossa política de privacidade para mais informações.
Recusar